Overview

The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol

Status:
Completed
Trial end date:
2020-01-22
Target enrollment:
Participant gender:
Summary
This study will evaluate the pharmacokinetics and pharmacodynamics of cannabidiol administered via inhalation and oral ingestion.
Phase:
Phase 1
Details
Lead Sponsor:
Johns Hopkins University
Treatments:
Cannabidiol